—HST
— • —
$20.14
P/E
18.28
PEG
0.02
FCF Yield
—
Rev Growth YoY
+757.0% YoY
Gross Margin
9501.0%
Health Score
5/10
D/E Ratio
0.77
Confidence
LOW
Business Snapshot
The ticker provided contains no exchange, sector, industry, or company name data, making a precise business description impossible from the payload alone. Based on available financial metrics, this appears to be a very small company — with a P/E of 18.28x and a Price/Sales of 2.24x — likely operating in a niche market. Without market capitalisation data, the cap tier cannot be formally classified, though the profile suggests micro- or small-cap territory.
Financial Health
**Score: 5/10** The financial profile contains several extraordinary-looking figures alongside meaningful gaps. Gross margin is reported at 9,501% and net margin at 1,251%, which are almost certainly the result of accounting distortions, restatements, or base-effect anomalies rather than genuine operating efficiency — a serious transparency concern...
Risk Assessment
- **DATA INTEGRITY:** Gross margin of 9,501% and net margin of 1,251% are economically implausible figures that strongly suggest accounting distortions, making all profitability conclusions unreliable. - **GROWTH BASE EFFECT:** Revenue growth of 757% YoY and earnings growth of 1,140% YoY almost certainly reflect an abnormally depressed prior-year base rather than sustainable organic expansion. - **CASH FLOW OPACITY:** Free Cash Flow is unavailable, meaning reported earnings cannot be validated against actual cash generation — a critical blind spot for any fundamental assessment. - **TECHNICAL DETERIORATION:** Price is trading below both the 50-day and 200-day moving averages, and a death cross formation is confirmed, indicating sustained downward price momentum. - **IDENTIFICATION RISK:** No company name, exchange, sector, or industry is provided, making peer comparison, regulatory context, and risk-category assessment impossible. ---...